GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Cyclically Adjusted FCF per Share

Arch Biopartners (TSXV:ARCH) Cyclically Adjusted FCF per Share : C$-0.02 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Arch Biopartners's adjusted free cash flow per share for the three months ended in Dec. 2023 was C$-0.009. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is C$-0.02 for the trailing ten years ended in Dec. 2023.

During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -17.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Arch Biopartners was 45.00% per year. The lowest was -26.00% per year. And the median was -2.70% per year.

As of today (2024-04-30), Arch Biopartners's current stock price is C$1.85. Arch Biopartners's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was C$-0.02. Arch Biopartners's Cyclically Adjusted Price-to-FCF of today is .


Arch Biopartners Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Arch Biopartners's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Cyclically Adjusted FCF per Share Chart

Arch Biopartners Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.02 -0.02 -0.02 -0.02

Arch Biopartners Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.02 -0.02 -0.02 -0.02

Competitive Comparison of Arch Biopartners's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Arch Biopartners's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arch Biopartners's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's Cyclically Adjusted Price-to-FCF falls into.



Arch Biopartners Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arch Biopartners's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.009/125.4675*125.4675
=-0.009

Current CPI (Dec. 2023) = 125.4675.

Arch Biopartners Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.002 98.604 -0.003
201406 -0.001 99.473 -0.001
201409 -0.003 99.394 -0.004
201412 -0.002 98.367 -0.003
201503 -0.003 99.789 -0.004
201506 -0.003 100.500 -0.004
201509 -0.001 100.421 -0.001
201512 -0.003 99.947 -0.004
201603 -0.003 101.054 -0.004
201606 -0.003 102.002 -0.004
201609 -0.004 101.765 -0.005
201612 -0.003 101.449 -0.004
201703 -0.003 102.634 -0.004
201706 -0.004 103.029 -0.005
201709 -0.004 103.345 -0.005
201712 -0.007 103.345 -0.008
201803 -0.012 105.004 -0.014
201806 -0.006 105.557 -0.007
201809 -0.013 105.636 -0.015
201812 -0.005 105.399 -0.006
201903 -0.012 106.979 -0.014
201906 -0.004 107.690 -0.005
201909 -0.009 107.611 -0.010
201912 -0.008 107.769 -0.009
202003 -0.008 107.927 -0.009
202006 -0.003 108.401 -0.003
202009 -0.012 108.164 -0.014
202012 -0.012 108.559 -0.014
202103 -0.008 110.298 -0.009
202106 -0.033 111.720 -0.037
202109 0.009 112.905 0.010
202112 0.017 113.774 0.019
202203 -0.002 117.646 -0.002
202206 -0.006 120.806 -0.006
202209 0.018 120.648 0.019
202212 -0.005 120.964 -0.005
202303 -0.015 122.702 -0.015
202306 0.009 124.203 0.009
202309 -0.014 125.230 -0.014
202312 -0.009 125.468 -0.009

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Arch Biopartners  (TSXV:ARCH) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Arch Biopartners Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Arch Biopartners (TSXV:ARCH) Business Description

Industry
Traded in Other Exchanges
N/A
Address
545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.